Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6549
    +0.0026 (+0.39%)
     
  • OIL

    83.75
    +0.18 (+0.22%)
     
  • GOLD

    2,360.10
    +17.60 (+0.75%)
     
  • Bitcoin AUD

    98,373.66
    +753.91 (+0.77%)
     
  • CMC Crypto 200

    1,390.03
    -6.50 (-0.47%)
     
  • AUD/EUR

    0.6096
    +0.0023 (+0.38%)
     
  • AUD/NZD

    1.0985
    +0.0027 (+0.25%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,107.72
    +28.86 (+0.36%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,056.07
    +138.79 (+0.77%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Sisram Medical Ltd (HKG:1696) Insiders Increased Their Holdings

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So shareholders might well want to know whether insiders have been buying or selling shares in Sisram Medical Ltd (HKG:1696).

What Is Insider Buying?

It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern insider transactions, and certain disclosures are required.

We don't think shareholders should simply follow insider transactions. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Harvard University study found that 'insider purchases earn abnormal returns of more than 6% per year.

ADVERTISEMENT

See our latest analysis for Sisram Medical

The Last 12 Months Of Insider Transactions At Sisram Medical

While no particular insider transaction stood out, we can still look at the overall trading.

You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

SEHK:1696 Recent Insider Trading, March 19th 2020
SEHK:1696 Recent Insider Trading, March 19th 2020

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Sisram Medical Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our information indicates that Sisram Medical insiders own about HK$284k worth of shares. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. We might be missing something but that seems like very low insider ownership.

So What Do The Sisram Medical Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Sisram Medical shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Sisram Medical stock. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Sisram Medical. You'd be interested to know, that we found 4 warning signs for Sisram Medical and we suggest you have a look.

But note: Sisram Medical may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.